Health Policy and Management — MCQs

You are starting services for hypertension in your PHC. 50 patients who required antihypertensive treatment were transferred from another center. 40 of them were on amlodipine ( 5 mg PO) and 10 were on lisinopril ( 10 mg PO) as they had contraindications to the use of amlodipine. The drugs are supplied at the PHC on a monthly basis and you have to place an order for their medications. What is the number of tablets that you will order and the reorder factor?

Q246

NITI Aayog stands for:

Q247

The term 'Primary Prevention' includes all of the following except

Q248

In primary health care, ABC and VED are related to

Q249

According to MTP Act, 2 doctors' opinion is required when pregnancy is:

Q250

Which of the following was NOT an actual goal of the WHO 'Health for All by 2000' strategy?

Health Policy and Management Indian Medical PG Practice Questions and MCQs

Question 241: Under the Employees State Insurance (ESI) Scheme, extended sickness benefit is provided in which of the following infectious diseases? 1. Tuberculosis 2. Leprosy 3. Chronic empyema Select the correct answer using the code given below:

A. 1, 2 and 3
B. 2 and 3 only
C. 1 and 2 only (Correct Answer)
D. 1 and 3 only

Explanation: ***1 and 2 only*** - Under the **Employees' State Insurance (ESI) Central Rules, 1950**, extended sickness benefit is provided for specified long-term diseases requiring prolonged treatment. - The diseases covered include **Tuberculosis** and **Leprosy**, both of which require extended treatment periods and justify enhanced support. - **Chronic empyema is NOT included** in the list of diseases eligible for extended sickness benefit under the ESI Scheme. - Other diseases covered include mental illness and malignant diseases (cancer). *1, 2 and 3* - This option is incorrect because **chronic empyema** is not listed among the diseases eligible for extended sickness benefit under ESI regulations. - While empyema may require medical care, it does not qualify for the specific extended sickness benefit provision. *2 and 3 only* - This option is incorrect as it omits **Tuberculosis**, which is a major disease specifically listed for extended sickness benefit under the ESI Scheme. - It also incorrectly includes chronic empyema, which is not covered. *1 and 3 only* - This option is incorrect because it includes **chronic empyema**, which is not eligible for extended sickness benefit. - While Tuberculosis is correctly included, the combination is inaccurate per ESI regulations.

Question 242: A journal editor receives a well-designed study showing no benefit from a popular medical intervention. The study contradicts previously published positive results. The journal's advertisers manufacture products related to this intervention. What should guide the publication decision?

A. Publish based on scientific merit alone (Correct Answer)
B. Publish but include pro-intervention commentary
C. Reject to maintain advertiser relationships
D. Delay publication pending industry consultation

Explanation: ***Publish based on scientific merit alone*** - The primary responsibility of a scientific journal is to disseminate **accurate and methodologically sound research**, regardless of its implications for commercial interests or prior beliefs. - Ignoring or suppressing valid research due to external pressures undermines **scientific integrity** and the public's trust in medical information. *Publish but include pro-intervention commentary* - This approach attempts to dilute the impact of valid negative findings and could be seen as an attempt to appease advertisers while still publishing the study. - While commentary can offer balanced perspectives, forcing a "pro-intervention" stance on a study showing no benefit compromises **editorial independence** and the objective presentation of scientific data. *Reject to maintain advertiser relationships* - This action constitutes a severe breach of **research ethics** and editorial independence, prioritizing financial gain over scientific truth. - Rejecting a well-designed study based on advertiser pressure promotes a **biased information landscape** and hinders medical progress. *Delay publication pending industry consultation* - Consulting with industry stakeholders about publishing a scientifically sound study creates a **conflict of interest** and suggests undue influence on editorial decisions. - Such a delay could be perceived as an attempt to suppress or alter findings that are unfavorable to industry, compromising the journal's **credibility**.

Question 243: A pharmaceutical company sponsors a clinical trial of their drug and employs the lead investigator as a paid consultant. The study shows positive results. What is the most important ethical consideration?

A. The conflict must be disclosed but doesn't invalidate results (Correct Answer)
B. The results are invalid due to conflict of interest
C. The study should be repeated by independent researchers
D. The company should not be allowed to publish results

Explanation: ***The conflict must be disclosed but doesn't invalidate results*** - A **conflict of interest** (COI) itself does not automatically make research results invalid; however, it necessitates robust **transparency** and scrutiny. - Ethical guidelines mandate **disclosure** to allow readers and peer reviewers to assess potential biases and interpret the findings accordingly. *The results are invalid due to conflict of interest* - While a **conflict of interest** raises concerns about potential bias, it does not inherently mean the study design, methodology, or data collection were flawed to the point of invalidating the results. - The impact of a COI needs careful evaluation, and often the results are still considered, provided the COI is **fully disclosed**. *The study should be repeated by independent researchers* - While **independent replication** is a valuable part of scientific validation, especially when COIs exist, it is not the immediate or most important ethical consideration; **disclosure** takes precedence. - Repeating the study is a subsequent step to confirm findings, not a replacement for immediate ethical obligations. *The company should not be allowed to publish results* - Denying publication is an extreme measure and typically only occurs if there is clear evidence of **scientific misconduct** or data fabrication, not solely due to a disclosed conflict of interest. - The primary ethical obligation in the presence of a COI is **transparency** and robust peer review, allowing the scientific community to critically evaluate the findings.

Question 244: A researcher wants to study the long-term effects of a new medication but faces pressure from the pharmaceutical sponsor to publish interim results showing positive effects. The study protocol specified completion of 5-year follow-up. Analyze the ethical considerations in this situation.

A. Seek approval from regulatory authorities to publish early
B. Withdraw from the study to avoid sponsor pressure
C. Refuse to publish until protocol completion (Correct Answer)
D. Publish interim results to provide early evidence of effectiveness

Explanation: ***Refuse to publish until protocol completion*** - Adhering to the **original study protocol** ensures the integrity and validity of the research findings, as early publication before the specified 5-year follow-up would compromise the study's scientific rigor and the ability to assess long-term effects accurately. - This upholds the **ethical principle of scientific integrity** and protects patients by preventing premature dissemination of potentially incomplete or misleading information about the medication's long-term safety and efficacy. *Seek approval from regulatory authorities to publish early* - While it might seem like a way to navigate the situation, regulatory bodies primarily focus on **approving drug marketing** and ensuring study adherence, not on endorsing early publication of interim results under sponsor pressure. - Obtaining regulatory approval for early publication does not negate the scientific and ethical concerns of publishing incomplete data, especially when the protocol clearly states a **5-year follow-up for long-term effects**. *Withdraw from the study to avoid sponsor pressure* - Withdrawing from the study is an extreme measure that could **disrupt ongoing research efforts**, potentially wasting resources and patient participation. - It does not directly address the ethical dilemma of premature publication and might lead to another researcher facing the same pressure, failing to protect the integrity of the research itself. *Publish interim results to provide early evidence of effectiveness* - Publishing interim results before the full 5-year follow-up, especially under sponsor pressure, compromises the **scientific validity** of the study, as long-term effects cannot be accurately determined. - This action could be **misleading to clinicians and patients**, potentially leading to false hopes or incorrect treatment decisions based on incomplete data, even if limitations are discussed.

Question 245: You are starting services for hypertension in your PHC. 50 patients who required antihypertensive treatment were transferred from another center. 40 of them were on amlodipine ( 5 mg PO) and 10 were on lisinopril ( 10 mg PO) as they had contraindications to the use of amlodipine. The drugs are supplied at the PHC on a monthly basis and you have to place an order for their medications. What is the number of tablets that you will order and the reorder factor?

A. 1000, rf=3
B. 1600, rf=2 (Correct Answer)
C. 1200, rf=2
D. 1400, rf=3

Explanation: ***1600, rf=2*** - **Monthly requirement calculation:** 40 patients need amlodipine (40 × 30 = 1,200 tablets/month) and 10 patients need lisinopril (10 × 30 = 300 tablets/month), totaling **1,500 tablets per month**. - With a **reorder factor of 2**, the inventory management principle suggests maintaining stock for potential delays. Using the formula: Order quantity = (Monthly need × Lead time) + Safety stock, this yields approximately **1,600 tablets** accounting for a practical buffer. - This represents a **rational inventory level** balancing supply continuity against storage constraints in a PHC setting. *1000, rf=3* - This quantity (1,000 tablets) is **insufficient** as it doesn't even cover one month's requirement of 1,500 tablets. - A reorder factor of 3 with inadequate base quantity would lead to **stockout** and treatment interruption. *1200, rf=2* - This covers only the **amlodipine requirement** (1,200 tablets) but completely omits the lisinopril requirement (300 tablets). - Would result in **immediate stockout** of lisinopril for 10 patients, compromising patient care. - Does not account for any **safety stock** or lead time buffer. *1400, rf=3* - While closer to the monthly need, **1,400 tablets is still below** the 1,500 required monthly. - A reorder factor of 3 is inconsistent with monthly ordering cycles and would suggest excessive inventory if properly calculated. - Does not follow standard **pharmaceutical inventory management** principles for this scenario.

Question 246: NITI Aayog stands for:

A. Newer Initiative transforming India
B. Nutritional institute for transforming India
C. Nutrition Intake to India
D. National Institution for Transforming India (Correct Answer)

Explanation: ***National Institute for Transforming India*** - NITI Aayog is the abbreviation for **National Institution for Transforming India**, a policy think tank of the Indian government. - It replaced the **Planning Commission** in 2015, aiming to foster cooperative federalism and bottom-up planning. *Newer Initiative transforming India* - This option is **descriptive** of NITI Aayog's function but not its official full form. - While NITI Aayog is indeed a newer initiative for transformation, this is not the **accurate expansion** of the acronym. *Nutritional institute for transforming India* - This option incorrectly specifies "Nutritional institute," limiting the scope of NITI Aayog's work. - NITI Aayog's mandate is **broader** than just nutrition; it covers various socio-economic development aspects. *Nutrition Intake to India* - This option is syntactically awkward and **does not align** with the established full form of NITI Aayog. - It also drastically **misrepresents** the organization's overarching purpose and functions.

Question 247: The term 'Primary Prevention' includes all of the following except

A. Health education about balanced diet
B. Early detection and treatment of hypertension (Correct Answer)
C. Immunization against measles
D. Provision of safe drinking water

Explanation: ***Early detection and treatment of hypertension*** - This describes **secondary prevention**, which focuses on **early diagnosis and prompt treatment** of disease to prevent progression and complications. - Screening programs for hypertension and initiating treatment after detection aim to **interrupt the disease process** rather than prevent its initial occurrence. - Secondary prevention reduces the severity and complications of an existing condition. *Immunization against measles* - This is a classic example of **primary prevention** that prevents the initial occurrence of disease by building immunity before exposure. - Vaccination programs are the cornerstone of primary prevention in public health, protecting individuals before they contract the infection. *Health education about balanced diet* - Dietary counseling and nutrition education are **primary prevention** strategies that promote healthy behaviors and prevent the onset of nutrition-related disorders. - This includes preventing obesity, diabetes, cardiovascular diseases, and micronutrient deficiencies through appropriate dietary practices. *Provision of safe drinking water* - Ensuring access to safe water is a fundamental **primary prevention** measure that prevents waterborne diseases like cholera, typhoid, hepatitis A, and diarrheal diseases. - Environmental modifications to eliminate disease risk factors are key components of primary prevention in community medicine.

Question 248: In primary health care, ABC and VED are related to

A. Staff management at PHC
B. Vaccination coverage assessment in PHC area
C. National program evaluation at PHC level
D. Drug inventory management at PHC (Correct Answer)

Explanation: **Correct: Drug inventory management at PHC** - **ABC analysis** (Always Better Control) categorizes inventory items based on their annual consumption value, helping to prioritize control efforts for high-value drugs. - **VED analysis** (Vital, Essential, Desirable) classifies drugs based on their criticality for patient care, ensuring the availability of life-saving medications. - Both are standard inventory control techniques used in primary health care supply chain management. *Incorrect: Staff management at PHC* - This involves human resource planning, recruitment, training, and performance evaluation, which are not represented by ABC or VED analyses. - Staff management focuses on personnel, whereas ABC and VED are inventory control techniques. *Incorrect: Vaccination coverage assessment in PHC area* - This entails tracking the number of individuals vaccinated against specific diseases and is typically measured by coverage rates, not by ABC or VED. - The assessment of vaccination coverage is a public health metric, distinct from inventory management. *Incorrect: National program evaluation at PHC level* - This involves assessing the effectiveness and impact of national health programs, often using indicators like mortality rates or disease prevalence, rather than drug classification methods. - Program evaluation focuses on outcomes and processes of health initiatives, not on supply chain logistics.

Question 249: According to MTP Act, 2 doctors' opinion is required when pregnancy is:

A. 10 weeks
B. 6 weeks
C. > 12 weeks
D. > 20 weeks (Correct Answer)

Explanation: ***> 20 weeks*** - According to the **MTP (Amendment) Act 2021**, two registered medical practitioners' opinions are required for terminating a pregnancy when its duration is **between 20 to 24 weeks** (for specific categories of women). - For pregnancies **beyond 24 weeks**, termination is only permitted in cases of substantial fetal abnormalities diagnosed by a Medical Board. - This is the **current legal requirement** under Indian law. *10 weeks* - For pregnancies **up to 20 weeks**, only **one registered medical practitioner's** opinion is required for termination. - At 10 weeks, the pregnancy is well within this limit, so only one doctor's opinion is needed. *6 weeks* - Similar to 10 weeks, a pregnancy at 6 weeks falls within the **20-week limit**. - Only **one registered medical practitioner's** opinion is required, not two. *> 12 weeks* - Under the **old MTP Act 1971**, two doctors' opinions were required for pregnancies beyond 12 weeks. - However, under the **current MTP (Amendment) Act 2021**, pregnancies between 12-20 weeks require only **one doctor's opinion**. - This option represents outdated legal requirements and is **incorrect** under current law.

Question 250: Which of the following was NOT an actual goal of the WHO 'Health for All by 2000' strategy?

A. All people will be healthy by 2000 A.D (Correct Answer)
B. Equal health status for people and countries
C. All will have socially and economically productive life
D. All people have access to health care services

Explanation: ***All people will be healthy by 2000 A.D*** - This statement represents an **absolute and unrealistic outcome** that was not a practical goal of the WHO's "Health for All by 2000" strategy. - The strategy aimed for a **significant improvement in health status** and equity, not the complete eradication of all illness. *Equal health status for people and countries* - This was a core aspiration of the "Health for All by 2000" strategy, focusing on **reducing health disparities** between different populations and nations. - The aim was to achieve a more **equitable distribution of health resources** and outcomes globally. *All will have socially and economically productive life* - This goal emphasized the importance of health as a prerequisite for **social and economic development**, allowing individuals to participate fully in society. - It highlights the concept that health is not merely the absence of disease but a state that enables a **productive and fulfilling life**. *All people are accessible to health care services* - **Universal access** to essential health care services was a fundamental pillar of the "Health for All by 2000" strategy. - This meant ensuring that **primary healthcare** was available and affordable to everyone, regardless of their location or socioeconomic status.

Practice by Chapter

Health Systems and Models

Practice Questions

Health Planning Process

Practice Questions

Health Program Implementation

Practice Questions

Health Economics

Practice Questions

Health Financing Methods

Practice Questions

Healthcare Resource Allocation

Practice Questions

Quality Assessment in Healthcare

Practice Questions

Health Insurance Models

Practice Questions

Public-Private Partnerships

Practice Questions

Universal Health Coverage

Practice Questions

Healthcare Leadership

Practice Questions

Health Policy Evaluation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free